Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Tien Liang BioTech Co., Ltd. (4127:TWSE), powered by AI.
Tien Liang BioTech Co., Ltd. is currently trading at $71.20. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Tien Liang BioTech Co., Ltd. on Alpha Lenz.
View Tien Liang BioTech Co., Ltd.'s valuation metrics on Alpha Lenz.
“Tien Liang BioTech Co., Ltd.'s ROE is -2.2%. Explore profitability and growth together.”
Ask for details →Tien Liang BioTech Co., Ltd. is a specialty and generic drug manufacturer headquartered in New Taipei City, Taiwan. Established in 1960, the company produces and markets an extensive range of pharmaceutical products, serving both domestic and international markets. Its portfolio includes traditional Chinese medicine formulations targeting conditions such as liver and kidney deficiencies, rheumatism, joint pain, and various common ailments such as coughs and colds. Tien Liang BioTech also offers western medicine products including ointments, tablets, capsules, pain relief gels, sprays, and patches. In addition to pharmaceuticals, the company manufactures health foods, personal care items, and specialty healthcare products designed for body relaxation and post-exercise comfort. With a focus on research and development, Tien Liang BioTech plays a vital role in advancing healthcare options within Taiwan and beyond, providing both consumer and wholesale solutions in the healthcare sector.
“Tien Liang BioTech Co., Ltd.'s ROE is -2.2%. Explore profitability and growth together.”
Ask for details →Tien Liang BioTech Co., Ltd. (ticker: 4127) is a company listed on TWSE in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 88 employees.
The current price is 71.2 with a P/E ratio of -x and P/B of -x.
ROE is -2.15% and operating margin is -3.15%. Annual revenue is $512M.